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Abstract
The relationship between stress and disease is thought to be unambiguous: chronic stress induces
immunosuppression, which likely increases the risk of infection. However, this link has not been firmly established
in wild animals, particularly whether stress hormones affect host responses to zoonotic pathogens, which can be
transmitted to domesticated animal, wildlife and human populations. Due to the dynamic effects of stress
hormones on immune functions, stress hormones may make hosts better or poorer amplifying hosts for a
pathogen contingent on context and the host species evaluated. Using an important zoonotic pathogen, West Nile
virus (WNV) and a competent host, the Northern Cardinal (Cardinalis cardinalis), we tested the effects of exogenous
corticosterone on response to WNV infection. Corticosterone was administered at levels that individuals enduring
chronic stressors (i.e., long-term inclement weather, food shortage, anthropogenic pollution) might experience in
the wild. Corticosterone greatly impacted mortality: half of the corticosterone-implanted cardinals died between
five - 11 days post-inoculation whereas only one of nine empty-implanted (control) birds died. No differences were
found in viral titer between corticosterone- and empty-implanted birds. However, cardinals that survived infections
had significantly higher average body temperatures during peak infection than individuals that died. In sum, this
study indicates that elevated corticosterone could affect the survival of WNV-infected wild birds, suggesting that
populations may be disproportionately at-risk to disease in stressful environments.
Introduction
Host exposure to stressors can have ramifications for the
spread, persistence or emergence of pathogens [1]. In
this paper, we consider a stressor to be any external fac-
tor that elicits a stress response that is characterized by
impairment of an organism’s ability to function normally,
including their capacity to mount an immune response
[2]. When an organism is exposed to a stressor, its resis-
tance to infection may be reduced through this suppres-
sion of the immune system [3-5]. Lowered resistance
may increase the chance of infection upon exposure to a
parasite/pathogen and/or lead to greater amplification of
the pathogen in the host. These effects might lead to
higher morbidity of the infected animal, enabling vectors
to obtain blood meals more effectively and become
infected themselves, thus spreading the infection more
easily. Whereas stress is well-associated with increased
susceptibility to disease [6],l i n k sa m o n gs t r e s s o r s ,t h e i r
physiological mediators, and resistance to pathogens are
not well established, especially in free-living animals.
Stressors might take many forms in natural systems
including inclement weather, food shortages, territorial
conflicts, or threat of predation [2]. In human-modified
landscapes, stressors may be even more common includ-
ing such factors as noise, air, and water pollution, greater
abundance of predators, and low-quality habitat and food
availability [7-9].
In the US, a particularly important zoonotic pathogen
is West Nile virus, or WNV. WNV causes morbidity
and mortality in birds, mammals, domestic livestock and
humans [10]. WNV has worldwide distribution; it has
been found in North America, Australia, Europe, Asia
and Africa [11]. For North American birds, WNV can
cause substantial morbidity and mortality, particularly
for some species of passerines [12-14], owls [15] and
sage grouse (Centrocercus urophasianus)[ 1 6 ] .T h e
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quitoes, primarily Culex spp., and Passeriform birds
[17]. Worldwide, WNV transmission primarily occurs in
urban and agricultural environments [11,18-20]. The
occurrence in urban environments is a pattern that has
been mainly attributed to the abundance of Cx. pipiens,
a mosquito that has adapted to anthropogenic habitats
[20]. The potential role of the avian host in the cluster-
ing of WNV cases in human dominated landscapes has
also received much attention [21-24]. Urban environ-
ments may support more competent host species than
rural areas; competence being defined as the host’s
capacity to replicate and transmit a parasite. Indeed,
species most competent for WNV (based on experimen-
tal infections) tend to be those that are common in
urban environments [25]. The above observations may
be biased because most experimental infection studies
have been conducted on resident, peridomestic species
[12,15,26-28], but see [29]. Moreover, in one of these
studies [12], very small samples sizes (e.g. n <5 )w e r e
used for most species, making it difficult to draw signifi-
cant conclusions about reservoir competence of some
species relative to others.
The response of any vertebrate to stressors is mediated
in large part by the hypothalamic-pituitary-adrenal
(HPA) axis and the secretion of glucocorticoids (GCs)
[2,30]. Although acute activation of the HPA axis can be
protective against infections [4], chronic elevations of
GCs tend to be detrimental, suppressing most, if not all,
immune defenses [3,31,32]. In birds, the primary gluco-
corticoid is corticosterone, and in response to chronic
stressors, plasma levels of corticosterone can be elevated
many-fold [33].
Our goal in the present study was to directly test the
effects of corticosterone elevation, to simulate exposure
to a chronic stressor, on the response of a passerine to
WNV infection. We predicted that administering exo-
genous corticosterone would elevate viremia (i.e., magni-
tude, or duration of virus circulation) due to immune
suppression (an effect previously seen in chickens [34]),
increase mortality and dampen the febrile response
upon infection. We tested our hypothesis using the
Northern Cardinal (Cardinalis cardinalis), a common
North American passerine distributed across the entire
eastern US, southern Canada and through northern
Central America [35]. We chose this species for several
reasons. First, cardinals are common visitors to bird fee-
ders, thus come into close contact with humans. Second,
cardinals are commonly infected with WNV and exhibit
some of the highest natural seroprevalence rates mea-
sured [36-39]. Finally, cardinals account for a high pro-
portion of the blood meals of the primary mosquito
vectors in some urban areas [40], suggesting that they
are a preferred host.
Materials and methods
Adult Northern Cardinals (n = 35; 15 females and 20
males) were captured in central Michigan, United States,
at several locations: Rose Lake State Wildlife Area in Bath,
MI, and sites in East Lansing, Okemos, Williamston and
Mason Townships in June and July 2009. Birds were target
netted using mist nets and playback of male cardinal
songs. Birds were transported to Michigan State University
animal research containment facility and housed in indivi-
dual cages (18 × 18 × 24in) within a biosafety level 3 ani-
mal room.
A blood sample (0.15 mL) was collected from each bird
and was screened for West Nile virus antibodies (see
below). Only birds confirmed as WNV-seronegative were
held for the experiment. Two of these birds died prior to
the experiment and one did not acclimate to captivity and
was subsequently released. Cardinals (n = 19; 9 females
and 10 males), stratified by sex, were randomly assigned to
treatment (n =1 0 ;5Fa n d5M )a n dc o n t r o l( n =9 ;4F
and 5 M) groups. Birds were maintained under natural
photoperiod specific to Michigan and fed ad libitum a
mixed diet of sunflower and safflower seed mix, soft food
mixture (puppy chow, carrots, and hardboiled eggs), meal-
worms and softened raisins.
On 25 July, all cardinals were inoculated subcuta-
neously with 10 000 plaque-forming units (pfu) of WNV
strain NY385-99, using methods described by Owen et al.
[29]. Blood was collected 10 h post-inoculation, and then
1 - 5 days post inoculation (dpi) at the same time of day
as inoculation. Whole blood (0.05 mL) was diluted with
BA-1 (0.45 mL; composed of Hank’s M-199 salts, 1%
bovine serum albumin, 350 mg/L sodium bicarbonate,
100 units/mL penicillin, 100 mg/L streptomycin, 1 mg/L
Fungizone in 0.05 M Tris, pH 7.6), immediately placed
on dry ice, and stored at -80°C.
All methods using animals in this study were
approved by the Michigan State University animal use
and care committee, IACUC protocol #01/10-007-00.
Body mass and temperature
At each blood sampling, birds were weighed to the near-
est 0.01 g and their body temperature to the nearest 0.1°
C was taken using a BAT-12 microprobe thermometer
and RET3 probe (Physitemp Instruments, Inc.) with tip
diameter of .065”, which was inserted into the cloaca.
Birds were sampled in the same order every day to mini-
mize the effect of time from initial disturbance on body
temperature. Birds were also examined daily for any clini-
cal signs of disease [41]. On 14 dpi, birds were bled (0.40
mL) and then euthanatized by CO2 inhalation.
West Nile virus titers
WNV titers were determined in duplicate using Vero
cell plaque assay in 6-well plates with a double 1.0%
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nd
and 3
rd day after the second overlay with neutral red
stain. Virus titer was log transformed and reported as
log pfu/mL of serum with the detection threshold for
the assays being 1.7 log pfu/mL serum. For two indivi-
duals on 3 dpi, viral plaques were too numerous to
count at a dilution that would be equivalent to 12 log
pfu/mL. However, when the assay was repeated at
higher dilutions, sample titers fell between 11-12 log
pfu/mL (lower values were likely due to viral degrada-
tion during prior freeze/thaw cycle). Therefore, a con-
servative 12.1 log pfu/mL titer was reported for these
individuals.
Plasma corticosterone
Plasma levels of corticosterone were measured using a
competitive enzyme immunoassay (EIA; Assay Designs
Inc., Ann Arbor, MI, USA) as described by Owen [43] and
validated for use in cardinals (Martin unpublished observa-
tions). All samples for an individual were assayed on the
same 96-well plate, in duplicate and in a random sequence.
Concentration of corticosterone is reported in ng/mL of
plasma. On 17 July 2009, after three-weeks in captivity,
blood samples were collected from all birds to measure
baseline corticosterone levels. Blood samples (0.075 mL)
were collected via brachial or jugular venipuncture within
three minutes of entering the housing room. On 20 July
2009, the treatment group (n = 10) was given corticoster-
one (Sigma C2505) implants (18 mm in length and 1.47
interior diameter) and the control group (n = 9) received
empty implants as described by Soma et al. [44]. The
implants were inserted subcutaneously under the right
wing and the incision site was sealed with a dermal adhe-
sive. Baseline CORT levels were sampled on 24 July (4 days
post-implant; dpm) and then again on 5 August. Due to
the amount of blood one can collect during a 2 week per-
iod of time, the stressful nature of collecting baseline corti-
costerone (i.e. large number of people quickly enter a
room, grab birds from cages and collect blood sample),
and limited access for most personnel during the active
infection period, we only sampled for baseline corticoster-
one -3 dpm, 4 dpm (-1 dpi) and 15 dpm (n). It is known
that corticosterone from implants can peak immediately
after implant and then drop to non-detectable levels, even
though the effect is pronounced for a period of time fol-
lowing implant [45]. The interassay coefficient of variation
for the two plates was 0.04.
Serology
Previous exposure to West Nile virus was assessed using a
blocking ELISA (enzyme-linked immunosorbent assay) for
specific WNV reactive antibodies as described by Blitvich
et al. [46]. For a serum sample to be considered positive
for WNV antibodies, it had to exhibit greater than 30%
inhibition relative to the negative control, uninfected
chicken serum (Vector Laboratories, Burlingame, CA,
USA). Following the experimental infection, blood was
collected at 14 dpi and assayed for WNV-specific antibody
titer using plaque-reduction neutralization test (PRNT)
[47]. The only modification to this method was the use of
6-well plates and inoculating those plates with 0.1 mL of
the virus-diluted blood sample. Antibody titers are
reported as the serum dilution that inhibited 90% of the
virus plaque formation.
Data analysis
Data were analyzed using Chi-square tests, independent
sample t-tests, or repeated measures ANOVA with treat-
ment group as independent variables and physiological
measures as response variables. When the sphericity
assumption was violated in the ANOVA tests, the Green-
house-Geisser test was used. All data presented as
described above passed assumptions of normality. Paired
t-tests were used for all post-hoc comparisons and alpha
adjusted for multiple comparisons. Pearson correlation
analyses were used to detect relationships between corti-
costerone concentration, body temperature, and virus titer
at the various sampling points. Baseline plasma corticos-
terone values were reported and analyzed as the difference
in concentration from pre-implant levels to control for
individual differences in starting concentration. We could
not test whether capture site impacted host responses due
to low statistical power. An alpha level of 0.05 was set for
all analyses and in each case; the derived P-value refers to
two-tailed tests. Analyses were performed with SPSS 18.0
(SPSS, Inc. Chicago, IL, USA).
Results
Viremia
All birds exhibited detectable levels of WNV post-infec-
tion (Figure 1). Peak viremia occurred on 3 dpi (Table 1)
with individual titers ranging from 4.8 to more than 12.1
log pfu/mL of blood. Virus titers during the 5-day period
post-inoculation did not differ between empty and corti-
costerone-implanted cardinals (F1, 15 =0 . 0 7 ,p = 0.80) or
between sexes (F1, 15 = 0.12, p = 0.74). Peak titer also did
not differ between treatments (t = 0.42, df = 17, p = 0.68).
However, peak titer did differ between birds that survived
and those that died during the experiment (t =3 . 3 8 ,df =
17, p = 0.004; Table 1): birds that died circulated signifi-
cantly more virus. To compare total viremia, integrals of
titers at each time interval were calculated for each indivi-
dual. However, there was no difference in total WNV
titers between the two groups (Mann Whitney U = 33.0,
p = 0.54). Infective duration could not be assessed because
all birds were still viremic on the last day of sampling.
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Five of the 10 corticosterone-implanted cardinals, but
only one of the 9 empty-implanted birds, died during
the experiment (Figure 2). Previous experimental infec-
tion studies with cardinals conducted under identical
protocols [27] resulted in a 22% (2 of 9 individuals)
mortality rate. Given this expected mortality rate for the
empty-implanted birds, the mortality rate observed in
the current experiment (11%, 1 in 9 individuals) did not
differ significantly (X
2 (1, N = 18) = 0.40, p = 0.53).
However, a mortality rate of 50% (5 of 10 individuals)
for the corticosterone-implanted birds trended toward
higher than the empty-implanted birds in current
experiment (X
2 (1, N = 19) = 3.32, p=0.069).
Body temperature
Regardless of treatment or survival, body temperature
increased between 0 dpi and peak viremia (2-5 dpi; 1 dpi
was excluded because it was measured at a different time
of day than all others; t = -7.68, df = 17, p < 0.001). How-
ever, birds that survived the infection exhibited higher
temperatures than individuals that died (Figure 3; F4, 68 =
2.89, p = 0.03). A second analysis further supported this
result: taking the average of body temperature during the
early viremic period (2-5 dpi) and subtracting this mean
from body temperature on 0 dpi, surviving birds exhib-
ited a larger febrile response during viremic period than
birds that died (t =2 . 3 6 ,df =1 7 ,p = 0.03). There was no
difference between corticosterone and control groups
Figure 1 Viremia profiles for (a) corticosterone-implanted and (b) empty-implanted Northern Cardinals infected with 10 000 pfu/mL of
West Nile virus.
Table 1 Daily mean (± SD) viremia titers (log pfu/mL serum) for Northern Cardinals (Cardinalis cardinalis) implanted
with either corticosterone (n = 10) or an empty silastic tubule (n = 9) and inoculated with a 10 000 pfu of West Nile
virus.
Min (above 1.69 log pfu*), Max Mean (SD)
Corticosterone Placebo Corticosterone Placebo
Survived
n =5
Died
n =5
Survived
n =8
Died
n =1
Survived
n =5
Died
n =5
Survived
n =8
1 dpi 3.2, 6.0 4.8, 6.2 3.2, 6.1 6.0 4.24 (1.06) 5.4 (0.55) 4.53 (1.16)
2 dpi 4.3, 7.2 6.8, 10.4 5.5, 9.0 10.1 5.68 (1.13) 8.8 (1.39) 6.58 (1.19)
3 dpi 4.8, 9.8 7.0, 12.1 5.4, 11.6 12.1 6.62 (1.9) 10.3 (1.96) 7.67 (2.28)
4 dpi 4.3, 5.4 6.4, 11.1 4.7, 10.5 8.3 4.9 (0.6) 10.2 (2.1) 6.29 (1.86)
5 dpi 3.7, 6.3 5.2, 10.4 1.7, 8.4 9.4 4.6 (1.11) 8.74 (2.23) 5.06 (2.46)
Minimum and maximum viral titers are reported for all birds with detectable levels on the given day. dpi = days post-injection. *1.69 log pfu is detection limit of
assay.
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corticosterone on body temperature over the entire vire-
mic period (F1, 17 = 2.26, p = 0.15).
Morbidity
Birds that died lost an average of 18% of their original (0
dpi) body mass compared to 2% mass loss in individuals
that survived (Figure 4; F1, 17 = 34.0, p < 0.001), but corti-
costerone implants did not affect mass loss (F1, 17 =0 . 1 6 ,
p = 0.70). Qualitative differences in clinical signs of dis-
ease between birds that survived and died were observed
including weakness, lethargy, anorexia, and ruffled feath-
ers. Some affected birds were unable to perch and laid in
sternal recumbency on the cage floor. Watery stool was
also observed on cage floors. A few of the birds
demonstrated tremors along with other clinical signs.
Upon necropsy, the birds that died from WNV had pro-
truding keels with very little furcular fat. Interestingly,
one control bird exhibited severe neurological disorder
and had difficulty balancing on the perch, but ultimately
recovered and survived to the end of the experiment.
Corticosterone
Plasma levels of corticosterone did not differ between
groups at pre-implant sampling (t =0 . 8 6 ,df =1 7 ,p =
0.40). Plasma corticosterone levels increased by 4 dpm in
both groups but the increase was greater in the corticos-
terone-implanted group, though not statistically significant
(Figure 5; t = -0.98, df =1 7 ,p = 0.34). Also, corticosterone
levels for birds that died during the experiment did not
differ from those that survived, either prior to (t = -1.63,
Figure 3 Body temperature (°C; mean ± 1SE) of Northern
Cardinals that survived or died from West Nile virus infection
for the five days post-inoculation.
Figure 4 Mean body mass (g; mean ± 1SE) of Northern
Cardinals that either died or survived a West Nile virus
infection at 0 days post-inoculation (dpi), peak viremia at
3 dpi, and either at death, or 14 dpi.
Figure 5 Changes in plasma corticosterone levels in empty-
implanted and corticosterone-implanted Northern Cardinals
from pre-implant levels to 4 and 15 days post-implant.
Figure 2 Effects of corticosterone or empty-implants on
survival of Northern Cardinals infected with 10,000 pfu/mL of
West Nile virus
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0.54). Virus titer on 1 dpi and 5 dpi were negatively corre-
lated to plasma corticosterone concentration on -1 dpm (1
dpi, r = -0.50, n = 18, p = 0.036; 5 dpi r = -0.54, n =1 7 ,
p = 0.025). There was no relationship between corticoster-
one on -1 dpm and virus titer on 2 - 4 dpi.
Discussion
Cardinals with exogenous corticosterone had 4.5 times
greater mortality than empty-implanted birds. While
this finding was not statistically significant (p =0 . 0 6 9 )
we would argue this difference is biologically significant.
However, corticosterone implants did not affect viral
titers, body temperature, body mass or circulating corti-
costerone levels. These effects are consistent with results
from other infection studies with other pathogens and
hosts [48]. For example, brown trout (Salmo trutto L.)
naturally infected with several different bacterial or fun-
gal pathogens had a dose-dependent increase in mortal-
ity when administered cortisol through intra-peritoneal
injection [49]. However, mice given exogenous corticos-
terone in their drinking water and then experimentally
inoculated with a highly pathogenic strain of avian influ-
enza (A/Vietnam/1203/04) did not exhibit differences in
mortality compared to non-treated controls [50], though
there were corticosterone-effects on mass with untreated
mice losing more mass than corticosterone administered
individuals. Likewise, chickens exposed to corticosterone
through their drinking water did not exhibit heightened
mortality to WNV, which may be attributed to their
overall low viremia regardless of treatment (peak viremia
3-5.0 pfu/mL of blood; [34]). The lack of effects of corti-
costerone on viremia in our cardinals is also contrary to
some other studies [34,51,52]. Chickens infected with
WNV and treated with corticosterone and with corticos-
terone and the toxicant, resmethrin, exhibited heigh-
tened, and prolonged viremia compared to controls and
resmethrin-only treated chickens. Likewise, domestic
dogs infected with WNV and administered a corticoster-
oid analog, methylprednisolone acetate, exhibited a
more intense (on average 40× greater) and longer vire-
mia than the untreated group [52].
Collectively, these results suggest corticosterone effects
on viremia and virus-induced mortality are diverse; how-
ever, these studies may not be directly comparable because
of the use of different pathogens, hosts, dosages, and
routes of administering corticosterone as well as the use of
synthetic GCs, which have different receptor binding
chemistry. In our study, corticosterone levels may have
been too low to affect viremia but sufficient to impact sur-
vival in some individuals. Perhaps had we assessed viremia
duration, corticosterone effects would have been detect-
able. On the other hand, a previous study in gray catbirds
(Dumetella carolinensis) found that peak WNV titer is
positively correlated to viremia duration (r = 0.40, n = 52,
p = 0.003; Owen unpublished data).
An intriguing additional possibility is that species differ
systematically in how corticosterone affects viremia. The
mortality without high viremia outcome in our study is
somewhat surprising because viremia is often positively
associated with mortality both among and within species;
typically, WNV-infected birds do not survive titers that
exceed 9.0 log pfu [12,15,28,53]. Furthermore, in our
study, all birds that died had peak titers of 10 log pfu or
greater, similar to our previous experimental infection
study [27]. However, contrary to other studies, some
individuals in our study had peak titers greater than
9.0 log pfu/mL and survived the experiment (Table 1).
These high titers in surviving cardinals is particularly
interesting with regards to their ability to serve as a reser-
voir for WNV. Based on reservoir competence index esti-
mates [12], cardinals from this study (assuming a
minimum index of 1.0, a conservative estimate because
we did not assess viremic duration) resemble species con-
sidered highly competent for WNV, such as American
robins (Turdus migratorius) and corvids [25]. Although
reservoir competence does not account for vector feeding
preference, in which robins are a considerably more pre-
ferred host than cardinals, our data suggest that popula-
tions and maybe even individuals, differ in their
competency to replicate and transmit viruses to vectors.
In other words, some species, including cardinals, might
be particularly important amplifying hosts for WNV,
especially in environments, such as urban areas, with
large amounts of endocrinological or immunological
variation.
Another unexpected outcome of the current study was
a lack of measurable elevation of circulating corticoster-
one post-implantation. Unlike some other corticosterone
implant studies, we did not leave open the implant ends,
which may have impeded diffusion of the hormone.
However, based on visual inspection of the implants
throughout the experimental period, corticosterone was
being released: at 14 days post-implant, each implant was
one half to two-thirds full with corticosterone. Moreover,
other studies too have found no change in circulating
corticosterone post-implant but with strong effects on
other physiological systems [45,54]. Finally, in a pilot
experiment testing the effect of having implants with
both ends sealed versus one end sealed in the baseline
corticosterone levels in American robins (Turdus migra-
torius) it was found that corticosterone was 100× and
200× greater 1 day post-implant, respectively (Owen
unpublished observations). Hence, it doesn’t appear that
having both ends sealed prevented the release of corticos-
terone and, furthermore, it was likely a more biologically
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there was a significant negative impact of corticosterone
on survival in the present study; no other factor differed
between treatment groups.
Corticosterone implants also did not affect body tem-
perature or antibody responses to WNV. However, dur-
ing the viremia period (2 ~ 4 dpi), birds that died had
lower body temperatures than birds that survived. These
increases in body temperature of 1-2°C are consistent
with febrile responses found in other birds [55,56]. The
importance of the febrile response in reducing morbidity
and mortality of infected animals has received some
support see review [57], but this is one of the first
experimental examples in a wild bird that fever is
related to survival of viral infection. Suppressive effects
of corticosterone on the release of pyrogenic cytokines
and production of prostaglandins, which mediate eleva-
tions in body temperature, are well-known [58,59], so it
was surprising to have observed no effects of the
implants on body temperature. However, capture, and
handling of birds prior to temperature measurements
may have obscured corticosterone effects on fever.
Future experimental infection studies could monitor
body temperature remotely (via telemetry) [60].
In summary, corticosterone implantations increased
Northern Cardinal mortality to WNV by 450%, but did
not affect viremia, mass or body temperature. However,
further research is necessary to determine whether these
results can be extrapolated to free-living individuals and
whether subtler changes in corticosterone may have dif-
ferent effects on mortality and viremia. Presently, our
data suggest populations in stressful environments may
suffer disproportionate mortality if exposed to WNV.
However, competence for WNV would seem to be
invariant or even reduced in such environments, as
birds with very high viremia would be expected to die
quickly, although in the current study most of the birds
survived through the first 5 days of infectious when a
bird is most viremic. We emphasize caution in making
such a strong conclusion though, as our data may be
unrepresentative of cardinal responses to WNV in the
wild. Free-living populations vary in their access to qual-
ity food resources, and those with greater access may be
able to endure stressors and perhaps serve as more
competent hosts for WNV in spite of elevated corticos-
terone. Indeed, field work to assess whether and how
natural and anthropogenic stressors affect the role of
cardinals and other species and populations in the
dynamics of WNV and other parasites is a critical yet
understudied area in disease ecology.
Abbreviations
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